Kindeva Drug Delivery L.P.

Kindeva is a pharmaceutical contract development and manufacturing organization (CDMO) that brings expertise, vision, and capabilities to help phrmaceutical and biotechnology companies realize their drug’s full potential. We help assess the feasibility of delivering a drug, then we develop the formulation and refine the delivery system for consistent results. We finalize product design and method validation, design the clinical plan, lead and support studies, and develop and register applications with regulatory authorities. We manufacture product and control the supply chain for global commercialization. Our global, cross-functional quality and regulatory teams make sure performance meets expectations in patients’ hands. We specialise in inhaled, transdermal and intradermal drug delivery.

Regulation (EU) No 517/2014 of the European Parliament and of the Council of 16 April 2014 on fluorinated greenhouse gases;
REACH (EC 1907/2006)

1

0.5

No lobbyists with EP accreditations

In 2020, 1 person was 50% allocated to engage in the EU F-gas review consultation via IPAC. Other Kindeva experts contribute to the subject matter.

Data not provided by Register Secretariat due to GDPR

Data not provided by Register Secretariat due to GDPR

II - In-house lobbyists and trade/business/professional associations

Companies & groups